Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.
作者信息
Mitchell Jonathan, Kim Jake, Alejo Jennifer L, Chiang Teresa P-Y, Karaba Andrew H, Blankson Joel N, Aytenfisu Tihitina Y, Chang Amy, Abedon Aura T, Avery Robin K, Tobian Aaron A, Massie Allan B, Levan Macey L, Warren Daniel S, Garonzik-Wang Jacqueline M, Segev Dorry L, Werbel William A
机构信息
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Surgery, Howard University College of Medicine, Washington, DC.
出版信息
Transplantation. 2022 May 1;106(5):e264-e265. doi: 10.1097/TP.0000000000004100. Epub 2022 Mar 14.
Abstract
摘要
相似文献
1
Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.接受贝拉西普治疗的肾移植受者对第三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗的体液和细胞免疫反应
Transplantation. 2022 May 1;106(5):e264-e265. doi: 10.1097/TP.0000000000004100. Epub 2022 Mar 14.
2
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept.在接受贝那普利特的肾移植受者中，SARS-CoV-2 mRNA 疫苗接种后的免疫原性和反应原性。
Transplantation. 2021 Sep 1;105(9):2119-2123. doi: 10.1097/TP.0000000000003824.
3
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.COVID-19 疫苗第四剂接种后成人实体器官移植受者的 SARS-CoV-2 刺突抗体。
Vaccine. 2022 Oct 19;40(44):6404-6411. doi: 10.1016/j.vaccine.2022.08.065. Epub 2022 Sep 6.
4
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse.第三剂疫苗可显著提高原发性体液无反应的肾移植受者的体液和细胞新冠病毒免疫力。
Kidney Int. 2021 Nov;100(5):1135-1136. doi: 10.1016/j.kint.2021.09.001. Epub 2021 Sep 9.
5
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients.抗代谢药物方案对实体器官移植受者接种 SARS-CoV-2 疫苗后细胞和体液免疫应答的影响。
Immunol Lett. 2024 Aug;268:106886. doi: 10.1016/j.imlet.2024.106886. Epub 2024 Jun 19.
6
Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.与透析患者和健康儿童相比，SARS-CoV-2 mRNA BNT162b2 疫苗在儿科肾移植受者中的体液和细胞免疫反应。
Pediatr Nephrol. 2023 Jul;38(7):2199-2208. doi: 10.1007/s00467-022-05813-w. Epub 2022 Dec 2.
7
Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept.接受贝拉西普治疗的肾移植受者接种SARS-CoV-2 mRNA疫苗后的免疫反应
Transplantation. 2021 Nov 1;105(11):e259-e260. doi: 10.1097/TP.0000000000003923.
8
Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.肾移植受者和透析患者对 SARS-CoV-2 的体液免疫：SARS-CoV-2 感染和接种疫苗后解析的 IgA 和 IgG 模式。
Virol J. 2024 Jun 13;21(1):138. doi: 10.1186/s12985-024-02410-1.
9
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.肾移植受者接受贝利尤单抗治疗后，对 3 剂 mRNA 疫苗的抗体反应较弱。
Am J Transplant. 2021 Dec;21(12):4043-4051. doi: 10.1111/ajt.16814. Epub 2021 Sep 12.
10
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.肾移植受者接种 3 剂 BNT162b2 mRNA SARS-CoV-2 疫苗后的细胞和体液免疫反应
Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.
引用本文的文献
1
Serologic Responses to COVID-19 Vaccination in Pediatric Kidney Transplant Recipients.儿童肾移植受者对新冠疫苗接种的血清学反应
Transplant Direct. 2025 Feb 7;11(3):e1756. doi: 10.1097/TXD.0000000000001756. eCollection 2025 Mar.
2
Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future.共刺激阻断与实体器官移植：过去、现在与未来
Kidney Int Rep. 2023 Sep 3;8(12):2529-2545. doi: 10.1016/j.ekir.2023.08.037. eCollection 2023 Dec.
3
A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation.一项新的随机对照试验：肺移植后基于贝利尤单抗的免疫抑制方案。
Transplantation. 2024 Mar 1;108(3):777-786. doi: 10.1097/TP.0000000000004841. Epub 2024 Feb 20.
4
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.实体器官移植受者对 SARS-CoV-2 感染的易感性和对 COVID-19 疫苗接种的免疫反应。
J Infect Dis. 2023 Aug 4;228(Suppl 1):S34-S45. doi: 10.1093/infdis/jiad152.
5
Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review.肾移植受者额外接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗剂量的有效性、免疫原性和危害：一项系统评价
Vaccines (Basel). 2023 Apr 18;11(4):863. doi: 10.3390/vaccines11040863.
6
Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIV.HIV感染者接种2剂和3剂SARS-CoV-2疫苗后的免疫原性和反应原性。
J Acquir Immune Defic Syndr. 2023 Jan 1;92(1):e3-e6. doi: 10.1097/QAI.0000000000003112.
7
SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.慢性肾脏病患者、透析患者或肾移植受者接种新冠疫苗后针对严重急性呼吸综合征冠状病毒2刺突蛋白的γ干扰素T细胞反应
Transplant Direct. 2022 Oct 18;8(11):e1387. doi: 10.1097/TXD.0000000000001387. eCollection 2022 Nov.
8
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.COVID-19 疫苗第四剂接种后成人实体器官移植受者的 SARS-CoV-2 刺突抗体。
Vaccine. 2022 Oct 19;40(44):6404-6411. doi: 10.1016/j.vaccine.2022.08.065. Epub 2022 Sep 6.
Zotero 插件